Porter S S, Goldberg R J
Can Anaesth Soc J. 1986 May;33(3 Pt 1):394-8. doi: 10.1007/BF03010756.
The presentation, evolution, and treatment of two cases of intraoperative allergic reactions are described. In each case, the offending agent was felt to be hydroxyethyl starch (HES), a synthetic polymer colloid solution used for intravascular volume expansion. Symptoms included urticaria, angioedema, and hypotension in the first patient, and urticaria, hypoxia, and haemoconcentration in the second patient. Both patients had earlier received multiple drugs and/or blood products. However, HES administration in both patients immediately produced allergic symptomatology. The first patient had concurrent depression of serum total complement levels (CH50) and no elevation of plasma histamine levels, which suggested a complement-mediated reaction to HES. Levels of CH50 and histamine were not obtained from the second patient. Direct stimulation of mast cell degranulation by the offending agent, complement activation, or conventional antigen-antibody interaction in a previously exposed patient may initiate intraoperative allergic reactions. Anaesthesia personnel should be aware of the risk of intraoperative allergic reactions to HES and be prepared to treat them rapidly and effectively.
本文描述了两例术中过敏反应的表现、进展及治疗情况。在每例病例中,引发过敏反应的药物被认为是羟乙基淀粉(HES),这是一种用于血管内容量扩充的合成聚合物胶体溶液。第一例患者的症状包括荨麻疹、血管性水肿和低血压,第二例患者的症状包括荨麻疹、低氧血症和血液浓缩。两名患者此前均接受过多种药物和/或血液制品治疗。然而,两名患者在输注HES后均立即出现过敏症状。第一例患者血清总补体水平(CH50)同时降低,血浆组胺水平未升高,提示对HES的补体介导反应。第二例患者未检测CH50和组胺水平。在既往有暴露史的患者中,引发过敏反应的药物直接刺激肥大细胞脱颗粒、补体激活或传统的抗原 - 抗体相互作用可能引发术中过敏反应。麻醉人员应意识到术中对HES发生过敏反应的风险,并准备好迅速有效地进行治疗。